Table 1.
Neuro-NICU eligibility and recommended neuromonitoring [adapted from Van Meurs et al. (20)].
| Diagnosis | Monitoring |
|---|---|
| 1. HIE/cooling | aEEG, cEEG |
| 2. Seizures | aEEG and cEEG |
| 3. ECMO/pre-ECMO | NIRS and consider aEEG |
| 4. Grade III/IV IVH or PHVD | aEEG |
| 5. Critical/unstable | NIRS and consider aEEG |
| 6. Preterms <28 weeks | aEEG and NIRS |
| 7. CNS anomalies cEEG | cEEG and/or aEEG |
| 8. Metabolic disease | cEEG and/or aEEG |
| 9. Cyanotic CHD | NIRS |
| 10. CNS infection | cEEG and/or aEEG |
| 11. Symptomatic PDA | NIRS |
| 12. ALTE/BRUE | aEEG |
| 13. Hyperbilirubinemia > 20 or hemolytic process | NIRS and consider aEEG |
ALTE, apparent life-threatening event; BRUE, brief resolved unexplained events; CNS, central nervous system; ECMO, extracorporeal membrane oxygenation; PDA, patent ductus arteriosus.